Payment overview · 2025
General Payments
$51.45
3 reported records · 2 companies
Healthcare provider profile · identity verified
Ronald L Rodriguez, DO
Allopathic & Osteopathic Physicians|Internal Medicine · CORSICANA, TX · NPI 1124093893
Verified facts
What the public records show
CMS Open Payments records show Ronald L Rodriguez, DO received $51.45 in general payments during 2025 across 3 reported records.
Lilly USA, LLC accounted for 61.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Trulicity by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $31.43 | 61.1% | 2 | 2025 |
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $20.02 | 38.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $51.45 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $31.43 | 2 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $31.43 | 2 | 2025 |
Source payment records
|
|||||
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $20.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 16 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
37 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
36 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 809 | 156 |
| Levothyroxine Sodium | Levothyroxine Sodium | 642 | 111 |
| Amlodipine Besylate | Amlodipine Besylate | 601 | 138 |
| Lisinopril | Lisinopril | 537 | 118 |
| Losartan Potassium | Losartan Potassium | 523 | 116 |
| Furosemide | Furosemide | 521 | 89 |
| Gabapentin | Gabapentin | 484 | 88 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 423 | 112 |
| Carvedilol | Carvedilol | 410 | 91 |
| Pantoprazole Sodium | Pantoprazole Sodium | 368 | 74 |
| Eliquis | Apixaban | 361 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 354 | 50 |
| Potassium Chloride | Potassium Chloride | 336 | 63 |
| Trazodone Hcl | Trazodone Hcl | 334 | 60 |
| Omeprazole | Omeprazole | 259 | 57 |
| Metoprolol Tartrate | Metoprolol Tartrate | 251 | 42 |
| Metformin Hcl | Metformin Hcl | 249 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 245 | 49 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 223 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 206 | 37 |
| Mirtazapine | Mirtazapine | 206 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 193 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 178 | 46 |
| Simvastatin | Simvastatin | 175 | 42 |
| Divalproex Sodium | Divalproex Sodium | 160 | 25 |
| Hydrochlorothiazide | Hydrochlorothiazide | 156 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 153 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 152 | 46 |
| Donepezil Hcl | Donepezil Hcl | 148 | 24 |
| Sertraline Hcl | Sertraline Hcl | 139 | 28 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 129 | 19 |
| Montelukast Sodium | Montelukast Sodium | 126 | 26 |
| Meloxicam | Meloxicam | 123 | 41 |
| Allopurinol | Allopurinol | 120 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 114 | 31 |
| Levetiracetam | Levetiracetam | 112 | 14 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 109 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 108 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 107 | 35 |
| Famotidine | Famotidine | 104 | 25 |
| Buspirone Hcl | Buspirone Hcl | 102 | 27 |
| Spironolactone | Spironolactone | 102 | 22 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 100 | 59 |
| Fluoxetine Hcl | Fluoxetine Hcl | 92 | 21 |
| Tramadol Hcl | Tramadol Hcl | 90 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 82 | 36 |
| Citalopram Hbr | Citalopram Hydrobromide | 80 | 22 |
| Memantine Hcl | Memantine Hcl | 80 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 80 | 20 |
| Celecoxib | Celecoxib | 79 | 21 |
| Myrbetriq | Mirabegron | 78 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 77 | 42 |
| Januvia | Sitagliptin Phosphate | 76 | 15 |
| Metformin Hcl Er | Metformin Hcl | 76 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 74 | 47 |
| Doxazosin Mesylate | Doxazosin Mesylate | 73 | 15 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 71 | 11 |
| Sucralfate | Sucralfate | 71 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | suppressed |
| Xarelto | Rivaroxaban | 60 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 58 | 13 |
| Glimepiride | Glimepiride | 58 | 16 |
| Finasteride | Finasteride | 56 | 13 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 56 | 18 |
| Ezetimibe | Ezetimibe | 54 | 13 |
| Lorazepam | Lorazepam | 53 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | suppressed |
| Prednisone | Prednisone | 51 | 20 |
| Latanoprost | Latanoprost | 50 | suppressed |
| Digoxin | Digoxin | 49 | suppressed |
| Pregabalin | Pregabalin | 48 | suppressed |
| Baclofen | Baclofen | 46 | suppressed |
| Nystatin | Nystatin | 45 | 25 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 44 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 43 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 42 | 25 |
| Insulin Aspart Flexpen | Insulin Aspart | 42 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 42 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 41 | suppressed |
| Novolog Flexpen | Insulin Aspart | 41 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | suppressed |
| Atenolol | Atenolol | 40 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 40 | 16 |
| Methylprednisolone | Methylprednisolone | 40 | 35 |
| Humalog Kwikpen U-100 | Insulin Lispro | 39 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Bumetanide | Bumetanide | 38 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 38 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 38 | suppressed |
| Jardiance | Empagliflozin | 37 | suppressed |
| Lactulose | Lactulose | 37 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 35 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Glipizide | Glipizide | 34 | 11 |
| Methocarbamol | Methocarbamol | 33 | 12 |
| Sodium Chloride | 0.9 % Sodium Chloride | 33 | suppressed |
| Synthroid | Levothyroxine Sodium | 33 | 11 |
| Warfarin Sodium | Warfarin Sodium | 33 | suppressed |
| Fluconazole | Fluconazole | 32 | 19 |
| Promethazine Hcl | Promethazine Hcl | 32 | suppressed |
| Clonazepam | Clonazepam | 31 | suppressed |
| Metolazone | Metolazone | 31 | 12 |
| Nystop | Nystatin | 31 | 19 |
| Rybelsus | Semaglutide | 31 | suppressed |
| Estradiol | Estradiol | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Risperidone | Risperidone | 29 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | suppressed |
| Erythromycin | Erythromycin Base | 28 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 28 | 11 |
| Azithromycin | Azithromycin | 27 | 15 |
| Cephalexin | Cephalexin | 27 | 23 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Meropenem | Meropenem | 27 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Levofloxacin | Levofloxacin | 26 | 18 |
| Lidocaine Hcl | Lidocaine Hcl | 26 | 18 |
| Ondansetron Odt | Ondansetron | 26 | suppressed |
| Ozempic | Semaglutide | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 25 | 11 |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Rivastigmine | Rivastigmine | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Mupirocin | Mupirocin | 24 | 15 |
| Torsemide | Torsemide | 24 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Lacosamide | Lacosamide | 23 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Multaq | Dronedarone Hcl | 23 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 20 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 20 | 19 |
| Letrozole | Letrozole | 20 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 19 | suppressed |
| Cefdinir | Cefdinir | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Levemir Flexpen | Insulin Detemir | 18 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Admelog Solostar | Insulin Lispro | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Temazepam | Temazepam | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $51.45 · 3 records | Lilly USA, LLC | INSPIRE, MOUNJARO, ZEPBOUND | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error